Improved biomarkers for prostate cancer: a definite need - PubMed (original) (raw)

Editorial

. 2004 Jun 2;96(11):813-5.

doi: 10.1093/jnci/djh174.

• PMID: 15173257
• DOI: 10.1093/jnci/djh174

Editorial

Improved biomarkers for prostate cancer: a definite need

H Ballentine Carter et al. J Natl Cancer Inst. 2004.

No abstract available

PubMed Disclaimer

Comment on

• Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer.
  Sreekumar A, Laxman B, Rhodes DR, Bhagavathula S, Harwood J, Giacherio D, Ghosh D, Sanda MG, Rubin MA, Chinnaiyan AM. Sreekumar A, et al. J Natl Cancer Inst. 2004 Jun 2;96(11):834-43. doi: 10.1093/jnci/djh145. J Natl Cancer Inst. 2004. PMID: 15173267

Similar articles

• Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer.
  Sreekumar A, Laxman B, Rhodes DR, Bhagavathula S, Harwood J, Giacherio D, Ghosh D, Sanda MG, Rubin MA, Chinnaiyan AM. Sreekumar A, et al. J Natl Cancer Inst. 2004 Jun 2;96(11):834-43. doi: 10.1093/jnci/djh145. J Natl Cancer Inst. 2004. PMID: 15173267
• [Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer].
  Mazzola CR, Ghoneim T, Shariat SF. Mazzola CR, et al. Prog Urol. 2011 Jan;21(1):1-10. doi: 10.1016/j.purol.2010.07.004. Epub 2010 Aug 14. Prog Urol. 2011. PMID: 21193139 Review. French.
• Detection of alpha-methylacyl-coenzyme-A racemase transcripts in blood and urine samples of prostate cancer patients.
  Zehentner BK, Secrist H, Zhang X, Hayes DC, Ostenson R, Goodman G, Xu J, Kiviat M, Kiviat N, Persing DH, Houghton RL. Zehentner BK, et al. Mol Diagn Ther. 2006;10(6):397-403. doi: 10.1007/BF03256217. Mol Diagn Ther. 2006. PMID: 17154657
• [Related biomarkers in the diagnosis of prostate cancer].
  Xu YM, Liu HZ. Xu YM, et al. Zhonghua Nan Ke Xue. 2015 Oct;21(10):937-40. Zhonghua Nan Ke Xue. 2015. PMID: 26665686 Review. Chinese.
• P504S expressing circulating prostate cells as a marker for prostate cancer.
  Murray NP, Calaf GM, Badinez L, Dueñas R, Badinez O, Orellana N, Reyes E, Fuentealba C. Murray NP, et al. Oncol Rep. 2010 Sep;24(3):687-92. doi: 10.3892/or_00000908. Oncol Rep. 2010. PMID: 20664974

Cited by

• The significance of monoamine oxidase-A expression in high grade prostate cancer.
  Peehl DM, Coram M, Khine H, Reese S, Nolley R, Zhao H. Peehl DM, et al. J Urol. 2008 Nov;180(5):2206-11. doi: 10.1016/j.juro.2008.07.019. Epub 2008 Sep 20. J Urol. 2008. PMID: 18804811 Free PMC article.
• Current early diagnostic biomarkers of prostate cancer.
  Qu M, Ren SC, Sun YH. Qu M, et al. Asian J Androl. 2014 Jul-Aug;16(4):549-54. doi: 10.4103/1008-682X.129211. Asian J Androl. 2014. PMID: 24830695 Free PMC article. Review.
• Translation research in prostate cancer.
  Makarov DV, Partin AW. Makarov DV, et al. Rev Urol. 2006 Spring;8(2):89-91. Rev Urol. 2006. PMID: 17021634 Free PMC article. No abstract available.
• Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.
  Orom H, Homish DL, Homish GG, Underwood W 3rd. Orom H, et al. Urol Oncol. 2014 May;32(4):396-402. doi: 10.1016/j.urolonc.2013.09.018. Epub 2013 Dec 12. Urol Oncol. 2014. PMID: 24332649 Free PMC article.
• New serum biomarkers for prostate cancer diagnosis.
  Chadha KC, Miller A, Nair BB, Schwartz SA, Trump DL, Underwood W. Chadha KC, et al. Clin Cancer Investig J. 2014;3(1):72-79. doi: 10.4103/2278-0513.125802. Clin Cancer Investig J. 2014. PMID: 25593898 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information